MIRM
Mirum Pharmaceuticals, Inc.Company with tickers: MIRM
CIK
1759425
CUSIP
604749101
Shares Outstanding
60,981,227
13F Activity (30d)
168 filings
164 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2023-04-17 | 2023-04-12 | |
| 8-K | 2023-05-04 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-06-13 | 2023-06-12 | |
| 8-K | 2023-07-17 | 2023-07-16 | |
| 8-K | 2023-08-03 | — | |
| 10-Q | 2023-08-07 | 2023-06-30 | |
| 8-K | 2023-08-30 | 2023-08-24 | |
| 8-K | 2023-09-05 | 2023-08-31 | |
| 8-K | 2023-09-11 | — | |
| 8-K | 2023-10-13 | — | |
| 8-K | 2023-10-17 | — | |
| 8-K/A | 2023-11-02 | 2023-08-31 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-12-18 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-16 | 2024-01-11 | |
| 8-K | 2024-02-28 | — | |
| 10-K | 2024-03-15 | 2023-12-31 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-31 | — | |
| 8-K | 2024-06-06 | 2024-06-05 | |
| 8-K | 2024-06-17 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2025-01-13 | — | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-05-30 | 2025-05-29 | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-11-17 | — | |
| 8-K | 2025-12-08 | 2025-12-06 | |
| 8-K | 2025-12-19 | — | |
| 8-K | 2025-12-19 | 2025-12-18 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-26 | 2026-01-23 | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K/A | 2026-04-08 | 2026-01-23 | |
| 8-K | 2026-04-27 | — | |
| 8-K | 2026-05-04 | — |
Showing 51–100 of 103 filings